OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Biotechnology is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial Board	196
Editorial Board	121
Corrigendum to “Methylotrophs: from C1 compounds to food” [Curr Opin Biotechnol 75 (2022) 102685]	110
Anaerobic microbial methanol utilization as a one-carbon feedstock	104
Bacterial degradation of emerging aromatic pollutants and integrated strategies for sustainable healthy agro-ecosystem	101
Tumor lipid metabolism: a mechanistic link between diet and cancer progression	94
Spatial enzyme assembly for microbial pharmaceutical synthesis	90
Cytochrome P450-mediated structural diversification of diketopiperazine alkaloids	86
Advances in synthetic microbial consortia for improved production of biochemicals and biofuels	80
Creating value from purple phototrophic bacteria via single-cell protein production	79
The osteo-angiogenic signaling crosstalk for bone regeneration: harmony out of complexity	76
Designing the future of food fats: precision fermentation of Yarrowia lipolytica for tailored lipid production	76
Synthetic biology advances towards a bio-based society in the era of artificial intelligence	75
How much could improving photosynthesis increase crop yields? A call for systems-level perspectives to guide engineering strategies	71
Unlocking the biotechnological potential of traditional fermented food microbiomes	68
Recent progress in the synthesis of advanced biofuel and bioproducts	66
Cell-free technologies for biopharmaceutical research and production	65
The journey of a lifetime — development of Pfizer’s COVID-19 vaccine	65
Editorial Board	65
Editorial Board	64
Innovations and trends in antibody repertoire analysis	64
Coupling chemistry and biology for the synthesis of advanced bioproducts	61
Molecular methods for high-throughput, multiplexed, and automated genome editing in prokaryotes and eukaryotes	61
Engineered living bioassemblies for biomedical and functional material applications	61
Metabolic engineering of microorganisms for the production of fatty acid-derived biofuels	59

A molecular assessment of the practical potential of DNA-based computation	59
Engineered T cells and macrophages: two arms to seize solid tumors	59
Deep learning in regulatory genomics: from identification to design	58
Microfluidics meets cell-free systems: from molecular engineering to synthetic cells	58
Emerging technologies for genetic control systems in cellular therapies	57
Lighting the way: recent developments and applications in molecular optogenetics	56
Strategies and challenges for synthetic apomixis	55
Recent advances, opportunities and challenges in cybergenetic identification and control of biomolecular networks	55
Expanding the catalytic repertoire of C–C bond–forming pyridoxal 5′-phosphate-dependent enzymes for noncanonical amino acid formation	53
Perspectives for self-driving labs in synthetic biology	52
Mass spectrometry imaging methods for visualizing tumor heterogeneity	52
Single-cell analysis opens a goldmine for plant functional studies	52
Photoprotective-based strategies to enhance crop yield under fluctuating light conditions	51
Next-generation brewing yeasts for non-alcoholic beers	51
Engineering of the genetic code	50
Biocatalytic cascade transformations for the synthesis of C-nucleosides and N-nucleoside analogs	48
Computational tools and resources for designing new pathways to small molecules	47
Deciphering the guanidine code: from core metabolism to biosynthesis of its derivatives	46
Emerging trends in production of plant natural products and new-to-nature biopharmaceuticals in yeast	46
Strategies for engineering domesticated and undomesticated human microbes	45
2-hydroxyglutarate rides the cancer-immunity cycle	45